SC 13G

Company

Benitec Biopharma Inc.

Filed

April 29, 2024

Accession Number

0001140361-24-022952

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →